Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biohaven (BHVN) Other Non-Current Liabilities (2021 - 2026)

Biohaven has reported Other Non-Current Liabilities over the past 6 years, most recently at $4.6 million for Q1 2026.

  • Quarterly results put Other Non-Current Liabilities at $4.6 million for Q1 2026, down 94.84% from a year ago — trailing twelve months through Mar 2026 was $4.6 million (down 94.84% YoY), and the annual figure for FY2025 was $4.6 million, down 1.72%.
  • Other Non-Current Liabilities reached $4.6 million in Q1 2026 per BHVN's latest filing, down from $4.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $268.3 million in Q3 2025 and bottomed at $2.2 million in Q4 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $4.6 million (2026), compared with a mean of $43.9 million.
  • The largest annual shift saw Other Non-Current Liabilities surged 5849.32% in 2025 before it crashed 94.84% in 2026.
  • Over 5 years, Other Non-Current Liabilities stood at $2.4 million in 2022, then decreased by 6.85% to $2.2 million in 2023, then skyrocketed by 107.71% to $4.7 million in 2024, then fell by 1.72% to $4.6 million in 2025, then decreased by 0.59% to $4.6 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for BHVN at $4.6 million in Q1 2026, $4.6 million in Q4 2025, and $268.3 million in Q3 2025.